Malignant thyroid teratoma of an adult: a long-term survival after chemotherapy

Am J Clin Oncol. 1998 Apr;21(2):212-4. doi: 10.1097/00000421-199804000-00025.

Abstract

Adult primary malignant teratoma of the thyroid is a rare disease that has a poor outcome despite aggressive therapy. A 32-year-old woman underwent a simple lobectomy of the thyroid for a progressively enlarged nodule in August 1990. Pathologic assessment of the tumor revealed a malignant teratoma. The physical examinations and image studies failed to find tumor in other sites. She subsequently received 6 courses of chemotherapy with cisplatin, etoposide, and bleomycin. She experienced a complete response to chemotherapy and remained disease-free for 6.5 years. This tumor must be included in the differential diagnosis of a thyroid tumor and may be treated as a testicular germ-cell tumor for which chemotherapy may be recommended.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Survivors
  • Teratoma / drug therapy*
  • Teratoma / surgery
  • Thyroid Neoplasms / drug therapy*
  • Thyroid Neoplasms / surgery

Substances

  • Bleomycin
  • Etoposide
  • Cisplatin